Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

Aciont is Profiled in this Database

Updated At 27 Jun, 2010

Start Free 7 Day Trial Now
Partial description of this company
Non-invasive, controlled, and sustained release back-of-the-eye therapeutics for sight-threatening diseases such as: severe uveitis, diabetic macular edema, and age-related macular degeneration (AMD)

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Aciont plus 4970 other startups.

Start Free 7 Day Trial Now

Learn More About Aciont

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation


Our Clients